KD Logo

Haemonetics Corp. [HAE] Shares Fall -1.22 % on Wednesday

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Haemonetics Corp. shares valued at $393,039 were sold by Strong Stewart W on Jul 26 ’24. At $91.15 per share, Strong Stewart W sold 4,312 shares. The insider’s holdings dropped to 18,196 shares worth approximately $1.38 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Also, Strong Stewart W purchased 4,312 shares, netting a total of over 393,039 in proceeds.

Before that, Lingamneni Anila had sold 2,136 shares from its account. In a trade valued at $192,240, the EVP, Chief Technology Officer traded Haemonetics Corp. shares for $90.00 each. Upon closing the transaction, the insider’s holdings decreased to 2,136 shares, worth approximately $1.62 million.

As published in their initiating research note from CL King on September 13, 2024, Haemonetics Corp. [HAE] has been a Buy and the price target has been revised to $116. Analysts at BofA Securities started covering the stock with ‘”a Neutral”‘ outlook in a report released in mid September. As of September 10, 2024, BTIG Research has initiated its “Buy” rating for HAE. Earlier on June 12, 2024, Needham upgraded its rating. Their new recommendation was “a Buy” for HAE stock which previously was a “a Hold”.

Analyzing HAE Stock Performance

During the last five days, there has been a surge of approximately 4.36%. Over the course of the year, Haemonetics Corp. shares have dropped approximately -11.58%. Shares of the company reached a 52-week high of $97.97 on 05/15/24 and a 52-week low of $70.74 on 02/14/24. A 50-day SMA is recorded $81.04, while a 200-day SMA reached $83.03. Nevertheless, trading volume fell to 0.71 million shares from 0.39 million shares the previous day.

Support And Resistance Levels for Haemonetics Corp. (HAE)

According to the 24-hour chart, there is a support level at 74.90, which, if violated, would cause prices to drop to 74.19. In the upper region, resistance lies at 76.43. The next price resistance is at 77.25. RSI (Relative Strength Index) is 46.36 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.56, which suggests the price will increase in the coming days. Percent R is at 44.51%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.

Most Popular